A patient death in a CRISPR trial halts gene editing studies, raising critical safety questions. What this means for the ...
This virtual event is part of the Transforming Pediatric Healthcare series from U.S. News & World Report, developed with ...
Qure N.V. (NASDAQ:QURE) surged around 15% in early trading on Friday after the company said it has secured a Type A meeting ...
Impella, which J&J touts as the world’s smallest heart pump, has a range of devices used for various heart conditions. Lexeo ...
By Karen Roman Biopharmaceutical company Medera Inc. said it completed patient enrollment for Cohort B of its clinical trial ...
A new CRISPR breakthrough shows scientists can turn genes back on without cutting DNA, by removing chemical tags that act ...
A preclinical study uncovered a new gene therapy that targets pain centers in the brain while eliminating the risk of ...
A new treatment might just be hope for many people living with chronic pain. In a recent preclinical study, researchers ...
U.K. biotech Ikarovec has teamed up with VectorBuilder to work on an eye disease gene therapy that could be administered in a ...
A retired HGV driver was the first person in the world to take part in a clinical trial to extend the lifespan of blood ...
News-Medical.Net on MSN
Gene therapy breakthrough could provide hope for millions living with chronic pain
A preclinical study uncovered a new gene therapy that targets pain centers in the brain while eliminating the risk of ...
A heart attack survivor is the first person to receive groundbreaking gene therapy which aims to prevent a major heart ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback